Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Incipiam Pharma ApS
APS
Active
Advertising protection
CVR 44074214
Ottiliavej 9, 2500
Valby
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2023 · 3 years old
2 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Incipiam Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
CT
Casper Tind Hansen
Chief Executive Officer
Chief Executive Officer
2023
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Gerhart-Hines Holding ApS
Company
20–24.99%
20–24.99%
2023
MTC 2008 HOLDING ApS
Company
20–24.99%
20–24.99%
2023
Bondo Hansen Holding ApS
Company
20–24.99%
20–24.99%
2023
CTH Holding Invest ApS
Company
20–24.99%
20–24.99%
2023
Receptor Holding ApS
Company
10–14.99%
10–14.99%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Incipiam Pharma ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
